Di Carli, Marcelo F <br/><br/>
Measurement of MBF by PET is ready for prime time as an integral part of clinical reports in diagnosis and risk assessment of patients with known or suspected CAD-PRO.  [electronic resource] 

 -  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology  Feb 2018 
 - 157-163 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-6551 
<br/><br/><label>Standard No.: </label>10.1007/s12350-017-1035-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Atherosclerosis--diagnostic imaging<br/>Cardiology--methods<br/>Constriction, Pathologic--diagnostic imaging<br/>Coronary Angiography<br/>Coronary Artery Disease--diagnostic imaging<br/>Coronary Circulation<br/>Humans<br/>Myocardial Perfusion Imaging<br/>Nuclear Medicine<br/>Positron-Emission Tomography<br/>Risk Assessment<br/>Societies, Medical<br/>United States